An association of UDP-Glucuronosyltransferase 2B7 C802T (His268 Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China

Toxicological Sciences

Volumn 85, Issue 1, 2005, Pages 502-506

  Lin, Guo Fang ^a   Guo, Wei Chao ^a   Chen, Ji Gang ^b   Qin, Yi Qing ^b   Golka, Klaus ^c   Xiang, Ciu Qing ^b   Ma, Qing Wen ^a   Lu, Da Ru ^d   Shen, Jian Hua ^a  

^a INSTITUTE OF PLANT PHYSIOLOGY AND ECOLOGY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c TU DORTMUND UNIVERSITY   (Germany)

^d FUDAN UNIVERSITY   (China)

Author keywords

Aromatic amines; Chinese; Glucuronidation; Transitional cell carcinoma

Indexed keywords

BENZIDINE; GLUCURONOSYLTRANSFERASE;

ARTICLE; BLADDER CANCER; BLOOD SAMPLING; CANCER RISK; CHINA; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ETHNOLOGY; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; POPULATION DISTRIBUTION; POPULATION RESEARCH; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TEXTILE INDUSTRY;

ASIAN CONTINENTAL ANCESTRY GROUP; BENZIDINES; CARCINOMA, TRANSITIONAL CELL; CHEMICAL INDUSTRY; CHINA; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLUCURONOSYLTRANSFERASE; HOMOZYGOTE; HUMANS; MALE; OCCUPATIONAL EXPOSURE; POLYMORPHISM, GENETIC; URINARY BLADDER NEOPLASMS;

EID: 18144382296     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfi068     Document Type: Article

References (32)

1. Babu, S. R., Lakshmi, V. M., Hsu, F. F., Zenser, T. V., and Davis, B. B. (1995). Glucuronidation of N-hydroxy metabolites of N-acetylbenzidine. Carcinogenesis 16, 3069-3074.
2. Babu, S. R., Lakshmi, V. M., Zenser, T. V., and Davis, B. B. (1994). Glucuronidation of N-acetylbenzidine by human liver. Drug. Metab. Dispos. 22, 922-927.
3. Bhasker, C. R., McKinnon, W., Stone, A., Lo, A. C., Kubota, T., Ishizaki, T., and Miners J. O. (2000). Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at antino acid 268: Ethnic diversity of alleles and potential clinical significance. Pharmacogenetics 10, 679-685.
4. Cartwright, R. A., Glashan, R. W., Rogers, H. J., Ahmad, R. A., Barham-Hall, D., Higgins, E., and Kahn, M. (1982). Role of N-acetyltransferase phenotypes in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer. Lancet 2 (8303), 842-846.
5. Ciotti, M., Lakshmi, V. M., Basu, N., Davis, B. B., Owens, I. S., and Zenser, T. V. (1999). Glucuronidation of benzidine and its metabolites by cDNA-expressed human UDP-glucuronosyltransferases and pH stability of glucuronides. Carcinogenesis 20, 1963-1969.
6. Coffman, B. L., King, C. D., Rios, G. R., and Tephly, T. R. (1998). The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268). Drug. Metab. Dispos. 26, 73-77.
7. Court, M. H., Krishnaswamy, S., Hao, Q., Duan, S. X., Patten, C. J., von Moltke, L. L., and Greenblatt D. J. (2003). Evaluation of 3′-azido-3′-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: Specificity and influence of the UGT2B7*2 polymorphism. Drug. Metab. Dispos. 31, 1125-1133.
8. Degen, G. H., Schlattjahn, J. H., Mähler, S., Föllmann, W., and Golka, K. (2004). Comparative metabolic activation of benzidine and N-acetylbenzidine by prostataglandin H synthase. Toxicol. Lett. 151, 135-142.
9. Desai, A. A., Innocenti, F., and Ratain, M. J. (2003). UGT pharmacogenomics: Implications for cancer risk and cancer therapeutics. Pharmacogenetics 13, 517-523.
10. Golka, K., Prior, V., Blaszkewicz, M., and Bolt, H. M. (2002). The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: A review considering ethnic differences. Toxicol Lett. 128, 229-241.
11. Golka, K., Prior, V., Blaszkewicz, M., Cascorbi, I., Schöps, W., Kierfeld, G., Roots, I., and Bolt, H. M. (1996). Occupational history aspects and genetic N-acetyltransferase (NAT2) polymorphism in urothelial cancer patients of Leverkusen, Germany. Scand. J. Work. Environ. Health 22, 332-338.
12. Golka, K., Reckwitz, T., Kempkes, M., Cascorbi, I., Blaszkewicz, M., Reich, S. E., Root, I., Soekeland, J., Schulze, H., and Bolt, H. M. (1997). N-Acetyltransferase 2 (NAT2) and glutathione S-transferase μ (GSTM1) in bladder cancer patients in a highly industrialized area. Int. J. Occup. Environ. Health 3, 105-110.
13. Hayes, R. B., Bi, W., Rothman, N., Broly, F., Caporaso, N., Feng, P., You, X., Yin, S., Woosley, R. L., and Meyer, U. A. (1993). N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers. Carcinogenesis 14, 675-678.
14. Holthe, M., Klepstad, P., Zahlsen, K., Borchgrevink, P. C., Hagen, L., Dale, O., Kaasa, S., Krokan, H. E., and Skorpen, F. (2002). Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy. Eur. J. Clin. Pharmacol. 58, 353-356.
15. IARC (1987). Monographs on the Evaluation of the Carcinogenic Risk to Humans. Suppl. 7. Overall Evaluations of Carcinogenicity. An Updating of IARC Monographs Vol. 1-42. International Agency for Research on Cancer, Lyon, France.
16. Jin, C. J., Miners, J. O., Burchell, B., and Mackenzie, P. I. (1993). The glucuronidation of hydroxylated metabolites of benzo[alpyrene and 2-acetylaminofluorene by cDNA-expressed human UDP-glucuronosyltransferases. Carcinogenesis 14, 2637-2639.
17. Lin, G. F., Ma, Q. W., Chen, J. G., Shen, J. H., Xiang, C. Q., Golka, K., and Zhang, D. S. (2001). Dependence of Papanicolaou gradings of exfoliated urothelial cells upon GSTMI and GSTTI polymorphism in benzidine-exposed workers of the Shanghai dye industry. Arch. Toxicol. 75, 544-548.
18. Ma, Q. W., Lin, G. F., Chen, J. G., Xiang, C. Q., Guo, W. C., Golka, K., and Shen, J. H. (2004). Polymorphism of N-acetyltransferase 2 (NAT2) gene polymorphism in Shanghai population: Occupational and non-occupational bladder cancer patient groups. Biomed. Environ. Sci. 17, 291-298.
19. Ma, Q. W., Lin, G. F., Qin, Y. Q., Lu, D. R., Golka, K., Geller, F., Chen, J. G., and Shen, J. H. (2003). GSTPI A1578G (Ile105Val) polymorphism in benzidine-exposed workers: An association with cytological grading of exfoliated urothelial cell. Pharmacogenetics 13, 409-415.
20. Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Belanger, A., Fournel-Gigleux, S., Green, M., Hum, D. W., and Iyanagi, T. (1997). The UDP glycosyltransferase gene superfamiliy: Recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7, 255-269.
21. Papanicolaou, G. N., and Marshall, V. F. (1945). Urine sediment smears: A diagnostic procedure in cancer of the urinary tract. Science 101, 519-520.
22. Papanicolaou, G. N. (1942). A new procedure for staining vaginal smears. Science 95, 438-439.
23. Radominska-Pandya, A., Little, J. M., and Czernik, P. J. (2001). Human UDP-glucuronosyltransferase 2B7. Curr. Drug. Metab. 2, 283-298.
24. Riedy, M., Wang, J. Y., Miller, A., Buckler, A., Hall, J., and Guida, M. (2000). Genomic organization of the UGT2b gene cluster on human chromosome 4q13. Pharmacogenetics 10, 251-260.
25. Sakaguchi, K., Green, M, Stock, N., Reger, T. S., Zunic, J., and King, C. (2004). Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms. Arch. Biochem. Biophys. 424, 219-225.
26. Sawyer, M. B., Innocenti, F., Das, S., Cheng, C., Ramirez, J., Pantle-Fisher, F. H., Wright, C., Badner, J., Pei, D., Boyett, J. M., et al.(2003). A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine. Clin. Phannacol. Ther. 73, 566-574.
27. Shen, J. H., Lin, G. F., Yuan, W. X., Tan, J. W., Bolt, H. M., and Thier, R. (1998). Glutathione transferase T1 and M1 genotype polymorphism in the normal population of Shanghai. Arch. Toxicol. 72, 456-458.
28. Wallig, M. A. (2004). Glucuronidation and susceptibility to chemical carcinogenesis. Toxicol. Sci. 78, 1-2.
29. Wise, R. W., Zenser, T. V., Kadlubar, F. F., and Davis, B. B. (1984). Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase. Cancer Res. 44, 1893-1897.
30. You, X. Y., Chen, J. G., and Yao, Y. F. (1983). A retrospective prospective investigation on bladder cancer in the workers exposed to benzidine in Shanghai dyestuff industry. Tumor 3, 197-201 (in Chinese).
31. Zenser, T. V, Laksmi, V M., Hsu, F. F., and Davis, B. B. (2002). Metabolism of N-acetylbenzidine and initiation of bladder cancer. Mutat. Res. 506-507, 29-40.
32. Zhang, D. S., Lin, G. E, Ma, Q. W., and Shen, J. H. (2002). Nonassociation of aryl hydrocarbon receptor genotypes with susceptibility to bladder cancer in Shanghai population. Acta Pharmacol. Sin. 23, 188-192.